These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32436945)

  • 1. A three-gene signature might predict prognosis in patients with acute myeloid leukemia.
    Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudogene BMI1P1 expression as a novel predictor for acute myeloid leukemia development and prognosis.
    Zhou LY; Zhai LL; Yin JY; Vanessa ME; Zhou J; Zhang J; Tang X; Lin J; Qian J; Deng ZQ
    Oncotarget; 2016 Jul; 7(30):47376-47386. PubMed ID: 27329719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Expression of Pseudogene POU5F1B Affects Diagnosis and Prognosis in Acute Myeloid Leukemia (AML).
    Yi J; Zhou LY; Yi YY; Zhu X; Su XY; Zhao Q; Lin J; Qian J; Deng ZQ
    Med Sci Monit; 2019 Jul; 25():4952-4959. PubMed ID: 31271156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
    Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
    DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octamer-binding transcription factor 4 correlates with complex karyotype, FLT3-ITD mutation and poorer risk stratification, and predicts unfavourable prognosis in patients with acute myeloid leukaemia.
    Xiang Y; Zhou X
    Hematology; 2018 Dec; 23(10):721-728. PubMed ID: 29950146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiality of Protein phosphatase Mg
    Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
    J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of OCT4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia.
    Yin JY; Tang Q; Zhai LL; Zhou LY; Qian J; Lin J; Wen XM; Zhou JD; Zhang YY; Zhu XW; Deng ZQ
    Tumour Biol; 2015 Dec; 36(12):9711-6. PubMed ID: 26152287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
    Zhang B; Yang L; Wang X; Fu D
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis.
    Yi YY; Yi J; Zhu X; Zhang J; Zhou J; Tang X; Lin J; Wang P; Deng ZQ
    J Cell Physiol; 2019 Apr; 234(4):3711-3719. PubMed ID: 30152863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-gene signature and clinical outcome in pediatric acute myeloid leukemia.
    Cai Z; Wu Y; Zhang F; Wu H
    Clin Transl Oncol; 2021 Apr; 23(4):866-873. PubMed ID: 32862280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.
    Torrebadell M; Díaz-Beyá M; Kalko SG; Pratcorona M; Nomdedeu J; Navarro A; Gel B; Brunet S; Sierra J; Camós M; Esteve J
    Leuk Lymphoma; 2018 Oct; 59(10):2394-2404. PubMed ID: 29390924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
    Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
    Front Immunol; 2021; 12():695865. PubMed ID: 34135913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.
    Metzeler KH; Maharry K; Kohlschmidt J; Volinia S; Mrózek K; Becker H; Nicolet D; Whitman SP; Mendler JH; Schwind S; Eisfeld AK; Wu YZ; Powell BL; Carter TH; Wetzler M; Kolitz JE; Baer MR; Carroll AJ; Stone RM; Caligiuri MA; Marcucci G; Bloomfield CD
    Leukemia; 2013 Oct; 27(10):2023-31. PubMed ID: 23765227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
    Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
    J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
    Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
    Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.
    Zhou LY; Yin JY; Tang Q; Zhai LL; Zhang TJ; Wang YX; Yang DQ; Qian J; Lin J; Deng ZQ
    Int J Clin Exp Pathol; 2015; 8(12):16073-80. PubMed ID: 26884884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia.
    Cao Y; Shu W; Jin P; Li J; Zhu H; Chen X; Zhu Y; Huang X; Cheng W; Shen Y
    Front Immunol; 2024; 15():1417398. PubMed ID: 38966636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.